These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3733284)

  • 1. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
    Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
    J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
    Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
    Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of hepatic bilirubin and paranitrophenol glucuronyl transferase activity. 3. Effect of rifampicin alone or associated with streptomycin and isoniazid in man].
    Hakim J; Feldmann G; Boivin P; Troube H; Boucherot J; Penaud J; Guibout P; Kreis B
    Pathol Biol (Paris); 1973 Mar; 21(3):255-63. PubMed ID: 4574487
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.
    Yamada S; Iwai K
    Lancet; 1976 Aug; 2(7981):366-7. PubMed ID: 60596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deviation in cortisol metabolism induced by rifampicin. Therapeutic consequences in adrenal failure (author's transl)].
    Bouchard P; Kuttenn F; Nahoul K; Mavier P; Schaison G; Mauvais-Jarvis P
    Nouv Presse Med; 1979 May; 8(20):1651-4. PubMed ID: 471734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cortisol metabolism following rifampicin therapy.
    Edwards OM; Courtenay-Evans RJ; Galley JM; Hunter J; Tait AD
    Lancet; 1974 Sep; 2(7880):548-51. PubMed ID: 4140269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
    Vital Durand D; Hampden C; Boobis AR; Park BK; Davies DS
    Br J Clin Pharmacol; 1986 Jan; 21(1):1-7. PubMed ID: 3947503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 16. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
    Brodie MJ; Boobis AR; Hillyard CJ; Abeyasekera G; MacIntyre I; Park BK
    Clin Pharmacol Ther; 1981 Sep; 30(3):363-7. PubMed ID: 7273600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.